{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:46:49Z","timestamp":1792093609501,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":787,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000135","name":"HHS | NIH | NIH Blueprint for Neuroscience Research","doi-asserted-by":"publisher","award":["U01 NS074476"],"award-info":[{"award-number":["U01 NS074476"]}],"id":[{"id":"10.13039\/100000135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"HHS | NIH | National Eye Institute (NEI)","doi-asserted-by":"publisher","award":["P30 EY019007"],"award-info":[{"award-number":["P30 EY019007"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"HHS | NIH | National Eye Institute (NEI)","doi-asserted-by":"publisher","award":["R24 EY019861"],"award-info":[{"award-number":["R24 EY019861"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness (RPB)","doi-asserted-by":"publisher","award":["unrestricted department funds"],"award-info":[{"award-number":["unrestricted department funds"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1074\/jbc.ra118.002062","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T17:40:21Z","timestamp":1528220421000},"page":"11574-11588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle"],"prefix":"10.1016","volume":"293","author":[{"given":"Boglarka","family":"Racz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Varadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rando","family":"Allikmets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Cioffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Petrukhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.002062_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0161-6420(13)31725-4","article-title":"Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus","volume":"101","author":"Birnbach","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1074\/jbc.RA118.002062_bib2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00006982-199515050-00005","article-title":"Hyperlipofuscinosis and subretinal fibrosis in Stargardt's disease","volume":"15","author":"De Laey","year":"1995","journal-title":"Retina"},{"key":"10.1074\/jbc.RA118.002062_bib3","series-title":"Retinal Pigment Epithelium and Macular Disease (Documenta Ophthalmologica)","first-page":"37","author":"Delori","year":"1995"},{"key":"10.1074\/jbc.RA118.002062_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0161-6420(80)35106-3","article-title":"Retinal pigment epithelial abnormalities in fundus flavimaculatus: a light and electron microscopic study","volume":"87","author":"Eagle","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1074\/jbc.RA118.002062_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13816810802695550","article-title":"Natural history of phenotypic changes in Stargardt macular dystrophy","volume":"30","author":"Walia","year":"2009","journal-title":"Ophthalmic Genet"},{"key":"10.1074\/jbc.RA118.002062_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev.pharmtox.47.120505.105225","article-title":"Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents","volume":"47","author":"Travis","year":"2007","journal-title":"Annu. Rev. Pharmacol"},{"key":"10.1074\/jbc.RA118.002062_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng0397-236","article-title":"A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy","volume":"15","author":"Allikmets","year":"1997","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.RA118.002062_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/humu.10263","article-title":"Genotyping microarray (gene chip) for the ABCR (ABCA4) gene","volume":"22","author":"Jaakson","year":"2003","journal-title":"Hum. Mutat"},{"key":"10.1074\/jbc.RA118.002062_bib9","first-page":"280","article-title":"Stargardt macular dystrophy: common ABCA4 mutations in South Africa\u2013establishment of a rapid genetic test and relating risk to patients","volume":"18","author":"Roberts","year":"2012","journal-title":"Mol. Vis"},{"key":"10.1074\/jbc.RA118.002062_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1517\/14728222.11.5.625","article-title":"New therapeutic targets in atrophic age-related macular degeneration","volume":"11","author":"Petrukhin","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1074\/jbc.RA118.002062_bib11","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.ddstr.2013.05.004","article-title":"Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment","volume":"10","author":"Petrukhin","year":"2013","journal-title":"Drug Discov. Today Ther. Strateg"},{"key":"10.1074\/jbc.RA118.002062_bib12","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.1167\/iovs.13-13214","article-title":"Understanding RPE lipofuscin","volume":"54","author":"Sparrow","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib13","first-page":"1855","article-title":"Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects","volume":"42","author":"Delori","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib14","first-page":"1691","article-title":"Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration","volume":"30","author":"Dorey","year":"1989","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib15","first-page":"195","article-title":"Aging human RPE: morphometric analysis of macular, equatorial, and peripheral cells","volume":"25","author":"Feeney-Burns","year":"1984","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib16","first-page":"1051","article-title":"Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration","volume":"42","author":"Holz","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib17","first-page":"478","article-title":"Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope","volume":"38","author":"von R\u00fcckmann","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchembio.759","article-title":"Primary amines protect against retinal degeneration in mouse models of retinopathies","volume":"8","author":"Maeda","year":"2011","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.RA118.002062_bib19","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1074\/jbc.M111.315432","article-title":"Mechanism of all-trans-retinal toxicity with implications for Stargardt disease and age-related macular degeneration","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.002062_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jamaophthalmol.2016.1466","article-title":"New understanding of age-related macular degeneration through quantitative autofluorescence","volume":"134","author":"Smith","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1074\/jbc.RA118.002062_bib21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archophthalmol.2010.18","article-title":"Complement, age-related macular degeneration and a vision of the future","volume":"128","author":"Gehrs","year":"2010","journal-title":"Arch. Ophthalmol"},{"key":"10.1074\/jbc.RA118.002062_bib22","first-page":"133","article-title":"The role of the complement system in age-related macular degeneration","volume":"111","author":"Weber","year":"2014","journal-title":"Dtsch. Arztebl. Int"},{"key":"10.1074\/jbc.RA118.002062_bib23","doi-asserted-by":"crossref","first-page":"e2593","DOI":"10.1371\/journal.pone.0002593","article-title":"Systemic complement activation in age-related macular degeneration","volume":"3","author":"Scholl","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1074\/jbc.RA118.002062_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.survophthal.2005.12.001","article-title":"The role of inflammation in the pathogenesis of age-related macular degeneration","volume":"51","author":"Donoso","year":"2006","journal-title":"Surv. Ophthalmol"},{"key":"10.1074\/jbc.RA118.002062_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/eye.1995.192","article-title":"Lipofuscin of the retinal pigment epithelium: a review","volume":"9","author":"Kennedy","year":"1995","journal-title":"Eye"},{"key":"10.1074\/jbc.RA118.002062_bib26","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1167\/iovs.05-0820","article-title":"Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases","volume":"46","author":"Radu","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib27","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1073\/pnas.0737855100","article-title":"Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration","volume":"100","author":"Radu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002062_bib28","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/mol.106.026823","article-title":"Effects of potent inhibitors of the retinoid cycle on visual function and photoreceptor protection from light damage in mice","volume":"70","author":"Maeda","year":"2006","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.RA118.002062_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tips.2010.03.001","article-title":"Retinoids for treatment of retinal diseases","volume":"31","author":"Palczewski","year":"2010","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-5793(92)81046-O","article-title":"In vitro interaction of fenretinide with plasma retinol-binding protein and its functional consequences","volume":"308","author":"Berni","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1074\/jbc.RA118.002062_bib31","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/jn\/123.9.1497","article-title":"N-(4-Hydroxyphenyl)retinamide (fenretinide) induces retinol-binding protein secretion from liver and accumulation in the kidneys in rats","volume":"123","author":"Schaffer","year":"1993","journal-title":"J. Nutr"},{"key":"10.1074\/jbc.RA118.002062_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/IAE.0b013e318265801d","article-title":"Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration","volume":"33","author":"Mata","year":"2013","journal-title":"Retina"},{"key":"10.1074\/jbc.RA118.002062_bib33","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/jcp.20774","article-title":"N-(4-Hydroxyphenyl)retinamide induces apoptosis in human retinal pigment epithelial cells: retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase-1 and Gadd153","volume":"209","author":"Samuel","year":"2006","journal-title":"J. Cell. Physiol"},{"key":"10.1074\/jbc.RA118.002062_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/kfp131","article-title":"Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance","volume":"111","author":"Cohen","year":"2009","journal-title":"Toxicol. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/tcm.1770080102","article-title":"Teratogenicity of N-(4-hydroxyphenyl)-all-trans-retinamide in rats and rabbits","volume":"8","author":"Kenel","year":"1988","journal-title":"Teratog. Carcinog. Mutagen"},{"key":"10.1074\/jbc.RA118.002062_bib36","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1021\/jm5010013","article-title":"Design, synthesis, and evaluation of non-retinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease","volume":"57","author":"Cioffi","year":"2014","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA118.002062_bib37","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1021\/acs.jmedchem.5b00423","article-title":"Bicyclic [3.3.0]-octahydrocyclopenta[c]pyrrolo antagonists of retinol binding protein 4: potential treatment of atrophic age-related macular degeneration and Stargardt disease","volume":"58","author":"Cioffi","year":"2015","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA118.002062_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1167\/iovs.12-10050","article-title":"A1120, a non-retinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis","volume":"54","author":"Dobri","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib39","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1074\/jbc.M809654200","article-title":"Identification and characterization of a non-retinoid ligand for retinol-binding protein 4 which lowers serum retinol-binding protein 4 levels in vivo","volume":"284","author":"Motani","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.002062_bib40","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/S0042-6989(03)00475-9","article-title":"A2E, a byproduct of the visual cycle","volume":"43","author":"Sparrow","year":"2003","journal-title":"Vis. Res"},{"key":"10.1074\/jbc.RA118.002062_bib41","doi-asserted-by":"crossref","first-page":"22276","DOI":"10.1074\/jbc.M111.329235","article-title":"Lipofuscin and N-retinylidene-N-retinylethanolamine (A2E) accumulate in retinal pigment epithelium in absence of light exposure: their origin is 11-cis-retinal","volume":"287","author":"Boyer","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.002062_bib42","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1073\/pnas.98.4.1835","article-title":"Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy","volume":"98","author":"Sieving","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002062_bib43","doi-asserted-by":"crossref","first-page":"E9675","DOI":"10.1073\/pnas.1712405114","article-title":"Dephosphorylation by protein phosphatase 2A regulates visual pigment regeneration and the dark adaptation of mammalian photoreceptors","volume":"114","author":"Kolesnikov","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002062_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/eye.1998.140","article-title":"Control of rhodopsin activity in vision","volume":"12","author":"Baylor","year":"1998","journal-title":"Eye (Lond)"},{"key":"10.1074\/jbc.RA118.002062_bib45","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1074\/jbc.M114.548669","article-title":"Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype","volume":"289","author":"Radu","year":"2014","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.002062_bib46","doi-asserted-by":"crossref","first-page":"18593","DOI":"10.1074\/jbc.M110.191866","article-title":"Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration","volume":"286","author":"Radu","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.002062_bib47","doi-asserted-by":"crossref","first-page":"16182","DOI":"10.1073\/pnas.0604255103","article-title":"Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium","volume":"103","author":"Zhou","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002062_bib48","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1167\/iovs.08-2868","article-title":"Complement activation by bisretinoid constituents of RPE lipofuscin","volume":"50","author":"Zhou","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib49","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1074\/jbc.M115.671180","article-title":"Complement component C5a primes retinal pigment epithelial cells for inflammasome activation by lipofuscin-mediated photooxidative damage","volume":"290","author":"Brandstetter","year":"2015","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.002062_bib50","first-page":"1981","article-title":"The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells","volume":"41","author":"Sparrow","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib51","first-page":"2988","article-title":"A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture","volume":"40","author":"Sparrow","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib52","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1073\/pnas.052025899","article-title":"The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium","volume":"99","author":"Finnemann","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002062_bib53","doi-asserted-by":"crossref","first-page":"24770","DOI":"10.1074\/jbc.M800706200","article-title":"The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells","volume":"283","author":"Vives-Bauza","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.002062_bib54","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/361724a0","article-title":"Retinal age pigments generated by self-assembling lysosomotropic detergents","volume":"361","author":"Eldred","year":"1993","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.002062_bib55","doi-asserted-by":"crossref","first-page":"15360","DOI":"10.1021\/bi0268551","article-title":"Retinol-binding protein-deficient mice: biochemical basis for impaired vision","volume":"41","author":"Vogel","year":"2002","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA118.002062_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0083-6729(06)75005-1","article-title":"Conversion of \u03b2-carotene to retinal pigment","volume":"75","author":"Biesalski","year":"2007","journal-title":"Vitam. Horm"},{"key":"10.1074\/jbc.RA118.002062_bib57","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1093\/emboj\/18.17.4633","article-title":"Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein","volume":"18","author":"Quadro","year":"1999","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA118.002062_bib58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0098-2997(03)00038-4","article-title":"Understanding the physiological role of retinol-binding protein in vitamin A metabolism using transgenic and knockout mouse models","volume":"24","author":"Quadro","year":"2003","journal-title":"Mol. Aspects Med"},{"key":"10.1074\/jbc.RA118.002062_bib59","first-page":"258","article-title":"A case of human vitamin A deficiency caused by an inherited defect in retinol-binding protein without clinical symptoms except night blindness","volume":"57","author":"Wolf","year":"1999","journal-title":"Nutr. Rev"},{"key":"10.1074\/jbc.RA118.002062_bib60","first-page":"3","article-title":"Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis","volume":"40","author":"Seeliger","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib61","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1167\/iovs.05-0089","article-title":"\u03b2-Carotene conversion into vitamin A in human retinal pigment epithelial cells","volume":"46","author":"Chichili","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci"},{"key":"10.1074\/jbc.RA118.002062_bib62","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.1073\/pnas.201301498","article-title":"Preservation of light signaling to the suprachiasmatic nucleus in vitamin A-deficient mice","volume":"98","author":"Thompson","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002062_bib63","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1753-4887.1995.tb01528.x","article-title":"Retinol transport and metabolism in transthyretin-\u201cknockout\u201d mice","volume":"53","author":"Wolf","year":"1995","journal-title":"Nutr. Rev"},{"key":"10.1074\/jbc.RA118.002062_bib64","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.1073\/pnas.0503318102","article-title":"Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle","volume":"102","author":"Golczak","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002062_bib65","doi-asserted-by":"crossref","first-page":"e0124940","DOI":"10.1371\/journal.pone.0124940","article-title":"Visual cycle modulation as an approach toward preservation of retinal integrity","volume":"10","author":"Bavik","year":"2015","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.002062_bib66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1530\/EJE-11-0431","article-title":"RBP4: a controversial adipokine","volume":"165","author":"Kotnik","year":"2011","journal-title":"Eur. J. Endocrinol"},{"key":"10.1074\/jbc.RA118.002062_bib67","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1128\/MCB.00820-12","article-title":"Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor \u03baB-dependent and retinol-independent mechanism","volume":"32","author":"Farjo","year":"2012","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.RA118.002062_bib68","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2014.01.018","article-title":"RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance","volume":"19","author":"Moraes-Vieira","year":"2014","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.RA118.002062_bib69","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1021\/bi0518545","article-title":"Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation","volume":"45","author":"Maiti","year":"2006","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.RA118.002062_bib70","doi-asserted-by":"crossref","first-page":"11668","DOI":"10.1073\/pnas.0403499101","article-title":"Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E","volume":"101","author":"Kim","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.002062_bib71","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1167\/iovs.09-3471","article-title":"Retinal pigment epithelium defects in humans and mice with mutations in MYO7A: imaging melanosome-specific autofluorescence","volume":"50","author":"Gibbs","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820315787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820315787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.002062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T04:33:16Z","timestamp":1641270796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820315787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":71,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0021925820315787"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.002062","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.002062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Racz et al.","name":"copyright","label":"Copyright"}]}}